The common HLA class I-restricted tumor-infiltrating T cell response in HPV16-induced cancer

MLA

Santegoets, S. J., et al. “The Common HLA Class I-Restricted Tumor-Infiltrating T Cell Response in HPV16-Induced Cancer.” Cancer Immunology, Immunotherapy, vol. 72, Dec. 2022, pp. 1553–65. EBSCOhost, https://doi.org/10.1007/s00262-022-03350-x.

APA

Santegoets, S. J., Welters, M. J. P., Schrikkema, D. S., Freriks, M. R., Kok, H., Weissbrich, B., Branden, A. van den, Linnemann, C., Schumacher, T. N., Adhikary, S., Bendle, G., & Burg, S. H. van der. (2022). The common HLA class I-restricted tumor-infiltrating T cell response in HPV16-induced cancer. Cancer Immunology, Immunotherapy, 72, 1553–1565. https://doi.org/10.1007/s00262-022-03350-x

Chicago

Santegoets, S.J., M.J.P. Welters, D.S. Schrikkema, M.R. Freriks, H. Kok, B. Weissbrich, A. van den Branden, et al. 2022. “The Common HLA Class I-Restricted Tumor-Infiltrating T Cell Response in HPV16-Induced Cancer.” Cancer Immunology, Immunotherapy 72 (December): 1553–65. doi:10.1007/s00262-022-03350-x.